Literature DB >> 8397917

Toxoplasmosis in the non-AIDS immunocompromised host.

D M Israelski1, J S Remington.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8397917

Source DB:  PubMed          Journal:  Curr Clin Top Infect Dis        ISSN: 0195-3842


× No keyword cloud information.
  52 in total

1.  Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis.

Authors:  N Schöler; K Krause; O Kayser; R H Müller; K Borner; H Hahn; O Liesenfeld
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Comparison of PCR-enzyme-linked immunosorbent assay and real-time PCR assay for diagnosis of an unusual case of cerebral toxoplasmosis in a stem cell transplant recipient.

Authors:  Jean Menotti; Gustavo Vilela; Stéphane Romand; Yves Jean-François Garin; Lionel Ades; Eliane Gluckman; Francis Derouin; Patricia Ribaud
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

3.  Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.

Authors:  Wai Kit Chew; Ignacio Segarra; Stephen Ambu; Joon Wah Mak
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

Review 4.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

5.  Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.

Authors:  Claudia Rozenfeld; Rodrigo Martinez; Sérgio Seabra; Celso Sant'anna; J Gabriel R Gonçalves; Marcelo Bozza; Vivaldo Moura-Neto; Wanderley De Souza
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

Review 6.  Effects of Toxoplasma gondii infection on the brain.

Authors:  Vern B Carruthers; Yasuhiro Suzuki
Journal:  Schizophr Bull       Date:  2007-02-23       Impact factor: 9.306

7.  PCR for diagnosis and follow-up of two cases of disseminated toxoplasmosis after kidney grafting.

Authors:  D Aubert; F Foudrinier; I Villena; J M Pinon; M F Biava; E Renoult
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

8.  Improved diagnosis of reactivated toxoplasmosis.

Authors:  D Ashburn; M M Davidson; A W Joss; T H Pennington; D O Ho-Yen
Journal:  Mol Pathol       Date:  1998-04

9.  Central nervous system toxoplasmosis with an increased proportion of circulating gamma delta T cells in a patient with hyper-IgM syndrome.

Authors:  L E Leiva; J Junprasert; D Hollenbaugh; R U Sorensen
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

10.  Toxoplasma H2A variants reveal novel insights into nucleosome composition and functions for this histone family.

Authors:  Maria C Dalmasso; David O Onyango; Arunasalam Naguleswaran; William J Sullivan; Sergio O Angel
Journal:  J Mol Biol       Date:  2009-07-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.